ENTITY
Pixium Vision Sa

Pixium Vision Sa (PIX FP)

37
Analysis
Health CareFrance
Pixium Vision SA develops retinal implant systems. The Company develops epi-retinal and sub-retinal implant systems to treat patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. Pixium Vision markets its systems throughout Europe.
more
Refresh
27 Jul 2022 16:52Issuer-paid

Pixium Vision - ESGO financing deal shores up balance sheet

Pixium has entered into a convertible notes financing arrangement with US-based healthcare investor European Select Growth Opportunities Fund...

Share
07 Mar 2022 20:36Issuer-paid

Pixium Vision - Moving ahead as expected

Pixium’s FY21 results were mostly in line with our forecasts, as the company continues to advance its wireless Prima bionic vision system (BVS)...

Share
20 Oct 2021 20:58Issuer-paid

Pixium Vision - Three-year data confirms continued Prima safety

Pixium reported 36-month data from its European feasibility study (PRIMA-FS) on the Prima implant in patients with geographic atrophy (GA)...

Share
05 Oct 2021 21:50Issuer-paid

Pixium Vision - Advancing towards sight restoration in dry-AMD

Prima, a potentially breakthrough wireless bionic vision system (BVS) that generates electrical impulses at the retinal level, continues to advance...

Share
16 Jul 2021 22:52Issuer-paid

Pixium Vision - Capital increase strengthens funding runway

On 13 July Pixium announced a €8m capital increase, which addresses a nearer-term funding need and should enable the company to focus on continuing...

Share
x